Literature DB >> 12764710

The brief symptom inventory and the positive and negative syndrome scale: discriminate validity between a self-reported and observational measure of psychopathology.

Neil J Preston1, Tracey J Harrison.   

Abstract

Concern within the literature has emerged from time to time arguing the poor validity of self-reported measures in psychopathology, namely, the reporting of psychotic experience. Although it is commonly believed that patients who have had a psychotic episode cannot accurately self-report their experience, very few studies have been conducted to measure the concordance between self-reported and observational measures of psychopathology using multivariate statistical techniques. Sixty-nine patients presenting their first psychotic episode were interviewed and assessed on the Positive and Negative Syndrome Scale (PANSS) and were asked to complete the Brief Symptom Inventory (BSI). By clustering symptom dimensions from the BSI into discriminate functions, the research demonstrated that these symptom dimensions could adequately classify high versus low scores on the PANSS subscales and total score. When the same clusters were entered into multivariate analysis of variance (MANOVA) models, they also demonstrated significant differences between high versus low observed symptomatology on the PANSS Positive and General Subscale Groups and Total Score Groups. The current findings shed some doubt on the supposition that those who experience psychosis are unable to report symptom dimensions that concord with those who observe the psychosis. It appears that models, operational definitions, and the language used in measuring psychopathology may differ significantly from those who experience the psychotic experience and those who observe it. Techniques such as multitrait multimethod are discussed as ways of overcoming these concerns.

Entities:  

Mesh:

Year:  2003        PMID: 12764710     DOI: 10.1016/S0010-440X(03)00010-5

Source DB:  PubMed          Journal:  Compr Psychiatry        ISSN: 0010-440X            Impact factor:   3.735


  9 in total

1.  Comparison of self-report and clinician-rated schizotypal traits in schizotypal personality disorder and community controls.

Authors:  Chi C Chan; Andrea Bulbena-Cabre; Sarah Rutter; Caridad Benavides; Margaret M McClure; William Calabrese; Daniel R Rosell; Harold W Koenigsberg; Marianne Goodman; Antonia S New; Erin A Hazlett; M Mercedes Perez-Rodriguez
Journal:  Schizophr Res       Date:  2019-01-08       Impact factor: 4.939

2.  Depressive symptoms, friend and partner relationship quality, and posttreatment abstinence.

Authors:  Laura G McKee; Marcel O Bonn-Miller; Rudolf H Moos
Journal:  J Stud Alcohol Drugs       Date:  2011-01       Impact factor: 2.582

3.  Pilot investigation: randomized-controlled analog trial for alcohol and tobacco smoking co-addiction using contingency management.

Authors:  Michael F Orr; Crystal Lederhos Smith; Myles Finlay; Samantha C Martin; Olivia Brooks; Oladunni A Oluwoye; Emily Leickly; Michael McDonell; Ekaterina Burduli; Celestina Barbosa-Leiker; Matt Layton; John M Roll; Sterling M McPherson
Journal:  Behav Pharmacol       Date:  2018-08       Impact factor: 2.293

4.  Does knee pain in the community behave like a regional pain syndrome? Prospective cohort study of incidence and persistence.

Authors:  K T Palmer; I Reading; M Calnan; C Linaker; D Coggon
Journal:  Ann Rheum Dis       Date:  2006-11-17       Impact factor: 19.103

5.  Routine outcomes monitoring to support improving care for schizophrenia: report from the VA Mental Health QUERI.

Authors:  Alexander S Young; Noosha Niv; Matthew Chinman; Lisa Dixon; Susan V Eisen; Ellen P Fischer; Jeffrey Smith; Marcia Valenstein; Stephen R Marder; Richard R Owen
Journal:  Community Ment Health J       Date:  2010-07-25

6.  Multilevel ordinal factor analysis of the positive and negative syndrome scale (PANSS).

Authors:  Jan Stochl; Peter B Jones; James Plaistow; Ulrich Reininghaus; Stefan Priebe; Jesus Perez; Tim J Croudace
Journal:  Int J Methods Psychiatr Res       Date:  2014-01-21       Impact factor: 4.035

7.  Can we trust the internet to measure psychotic symptoms?

Authors:  Steffen Moritz; Niels Van Quaquebeke; Tania M Lincoln; Ulf Köther; Christina Andreou
Journal:  Schizophr Res Treatment       Date:  2013-07-10

8.  Prevalence and Correlates of Cannabis Use in Outpatients with Serious Mental Illness Receiving Treatment for Alcohol Use Disorders.

Authors:  Jordan Skalisky; Emily Leickly; Oladunni Oluwoye; Sterling M McPherson; Debra Srebnik; John M Roll; Richard K Ries; Michael G McDonell
Journal:  Cannabis Cannabinoid Res       Date:  2017-06-01

9.  The Brief Symptom Inventory and the Outcome Questionnaire-45 in the Assessment of the Outcome Quality of Mental Health Interventions.

Authors:  Aureliano Crameri; Christopher Schuetz; Andreas Andreae; Margit Koemeda; Peter Schulthess; Volker Tschuschke; Agnes von Wyl
Journal:  Psychiatry J       Date:  2016-09-08
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.